A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD

por Srivastava, Rai Ajit K.
Publicado 2023

A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes

por Srivastava, Rai Ajit K., Mistry, Sapna, Sharma, Somesh
Publicado 2015

Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors: Implication for...

por Bisgaier, Charles L., Oniciu, Daniela C., Srivastava, Rai Ajit K.
Publicado 2018

Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism

por Srivastava, Rai Ajit K., Cornicelli, Joseph A., Markham, Bruce, Bisgaier, Charles L.
Publicado 2018